Eupraxia Pharmaceuticals (EPRX) Stock Price, News & Analysis

Company Overview

Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company. It focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. Th company's lead product candidate includes EP-104IAR, for the treatment of pain due to osteoarthritis of the knee. Eupraxia Pharmaceuticals Inc. is based in VICTORIA, BC.

Key Stats

• Today's Range: $2.82 to $2.94
• 50-Day Range: $2.40 to $2.87
• 52-Week Range: $2.39 to $5.58
• Volume: 5,048 shs
• Average Volume: 15,851 shs
• Market Capitalization: $78.41 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Buy

EPRX Stock Analysis - Frequently Asked Questions

How have EPRX shares performed this year?

Eupraxia Pharmaceuticals' stock was trading at $2.72 at the beginning of 2024. Since then, EPRX shares have increased by 5.7% and is now trading at $2.8742.
View the best growth stocks for 2024 here.

How were Eupraxia Pharmaceuticals' earnings last quarter?

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) issued its quarterly earnings results on Wednesday, August, 7th. The company reported ($0.17) earnings per share (EPS) for the quarter.

Who are Eupraxia Pharmaceuticals' major shareholders?

Eupraxia Pharmaceuticals' top institutional investors include 180 Wealth Advisors LLC (0.05%).

How do I buy shares of Eupraxia Pharmaceuticals?

Shares of EPRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Last Earnings: 8/07/2024
• Today: 9/21/2024
• Next Earnings (Estimated): 11/12/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:EPRX
• Previous Symbol: NASDAQ:EPRX
• CUSIP: N/A
• CIK: 1581178
• Web: www.eupraxiapharma.com
• Phone: 250-590-3968
• Fax: N/A
• Employees: 29
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.00)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-28,220,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -208.37%
• Return on Assets: -82.29%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.11
• Quick Ratio: 2.11

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.03 per share
• Price / Book: 95.81

Miscellaneous

• Outstanding Shares: 27,282,000
• Free Float: N/A
• Market Cap: $78.41 million
• Optionable: N/A
• Beta: N/A